Eva Maria Fenyö
51 – 60 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Quantitative evaluation of HIV and SIV co-receptor use with GHOST(3) cell assay.
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets
(
- Contribution to journal › Article
-
Mark
The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission
(
- Contribution to journal › Article
-
Mark
Plaque-reduction assays for human and simian immunodeficiency virus neutralization.
(
- Contribution to journal › Article
-
Mark
Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation
(
- Contribution to journal › Article
-
Mark
Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.
(
- Contribution to journal › Article
-
Mark
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
(
- Contribution to journal › Article
- 2004
-
Mark
Primate models for human immunodeficiency virus infection. Evolution of receptor use during pathogenesis.
(
- Contribution to journal › Article
-
Mark
Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
(
- Contribution to journal › Article
- 2003
-
Mark
HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
(
- Contribution to journal › Article